Salesforce
CRM
Oracle
ORCL
Coinbase
COIN
4
Microsoft
MSFT
5
Adobe
ADBE
US Stock MarketDetailed Quotes
SMMT Summit Therapeutics
- 34.350
- +1.120+3.37%
Trading Apr 24 10:43 ET
25.34BMarket Cap-110.81P/E (TTM)
34.530High32.480Low2.04MVolume33.000Open33.230Pre Close68.27MTurnover1.77%Turnover RatioLossP/E (Static)737.68MShares34.53052wk High65.18P/B3.96BFloat Cap2.10052wk Low--Dividend TTM115.17MShs Float34.530Historical High--Div YieldTTM6.17%Amplitude0.660Historical Low33.532Avg Price1Lot Size
Summit Therapeutics Key Stats
EPS
According to the latest financial report of Summit Therapeutics, the latest earnings per share (TTM) for the company is -0.09. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Summit Therapeutics's free cash flow? The latest report shows it as -48.69M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Summit Therapeutics shows that the company's current ratio is 10.15, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Summit Therapeutics, the quick ratio is 9.89, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Summit Therapeutics? The latest ROE figure is -14.81%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Summit Therapeutics, the total asset return on investment (ROA) is -13.04%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Summit Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Summit Therapeutics, the net profit margin is -9.72K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025